Acasti Pharma, Inc. (ACST) will effect a one-for-eight (1-8) reverse split of its common stock. The reverse stock split will become effective on Tuesday, August 31, 2021.

Is Acst going to merge?

(“Acasti”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of its previously disclosed acquisition of Grace Therapeutics, Inc. (“Grace”) via merger. The successful completion of the merger positions Acasti to build a premier, late-stage specialty pharma company focused on rare diseases.

Is Acst a good investment?

Out of 1 analysts, 0 (0%) are recommending ACST as a Strong Buy, 0 (0%) are recommending ACST as a Buy, 0 (0%) are recommending ACST as a Hold, 0 (0%) are recommending ACST as a Sell, and 1 (100%) are recommending ACST as a Strong Sell.